Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer
$731,780R44FY2019CANIH
Encodia, Inc., San Diego CA
Investigators
Linked publications, trials & patents
Abstract
ABSTRACT Next generation sequencing (NGS) has transformed the field of genomics and enabled broad adoption of the technology in biological, translational, and most recently clinical research. The proteomics equivalent to NGS has not yet been realized. As such, the goal of this proposal is to develop a highly-scalable digital protein analysis technology. The approach is broadly applicable and greatly improves upon cost, sensitivity, usability, and throughput of current approaches.
View original record on NIH RePORTER →